Lessons From Prospective Longitudinal Follow-up of a French APECED Cohort
- PMID: 38605470
- PMCID: PMC11834711
- DOI: 10.1210/clinem/dgae211
Lessons From Prospective Longitudinal Follow-up of a French APECED Cohort
Abstract
Background: Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome is a rare disease caused by biallelic mutations of the AIRE gene, usually presenting with the triad hypoparathyroidism-adrenal failure-chronic mucocutaneous candidiasis (CMC) and nonendocrine manifestations. The aim of this study was to determine the molecular profile of the AIRE gene, the prevalence of rare manifestations, and to characterize immunological disturbances in a French cohort.
Patients and methods: A national, multicenter prospective observational study to collect genetic, clinical, biological, and immunological data (NCT03751683).
Results: Twenty-five patients (23 families) were enrolled. Eleven distinct AIRE variants were identified, 2 of which were not previously reported: an intronic variant, c.653-70G > A, and a c.1066del (p.Arg356GlyfsX22) variant (exon 9). The most common was the Finnish variant c.769C > T (16 alleles), followed by the variant c.967_979del13 (15 alleles), which seemed associated with a less severe phenotype. Seventeen out of 25 patients were homozygote. The median number of clinical manifestations was 7; 19/25 patients presented with the hypoparathyroidism-adrenal failure-CMC triad, 8/13 showed pulmonary involvement, 20/25 had ectodermal dystrophy, 8/25 had malabsorption, and 6/23 had asplenia. Fifteen out of 19 patients had natural killer cell lymphopenia with an increase in CD4+ and CD8+ T lymphocytes and an age-dependent alteration of B lymphocyte homeostasis compared with matched controls (P < .001), related to the severity of the disease. All tested sera (n = 18) were positive for anti-interferon-α, 15/18 for anti-IL-22 antibodies, and 13/18 for anti-IL-17F antibodies, without clear phenotypic correlation other than with CMC.
Conclusion: This first prospective cohort showed a high AIRE genotype variability, with 2 new gene variants. The prevalence of potentially life-threatening nonendocrine manifestations was higher with systematic screening. These manifestations could, along with age-dependent B-cell lymphopenia, contribute to disease severity. Systematic screening for all the manifestations of the syndrome would allow earlier diagnosis, supporting vaccination and targeted therapeutic approaches.
Keywords: AIRE genotype; APECED syndrome; asplenia; autoimmune polyendocrine syndrome type 1; pulmonary involvement.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.
Figures



Similar articles
-
Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.Br J Dermatol. 2006 Jun;154(6):1088-93. doi: 10.1111/j.1365-2133.2006.07166.x. Br J Dermatol. 2006. PMID: 16704638
-
Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.J Clin Immunol. 2014 Feb;34(2):181-93. doi: 10.1007/s10875-014-9987-5. Epub 2014 Feb 4. J Clin Immunol. 2014. PMID: 24493573
-
Report of two siblings with APECED in Serbia: is there a founder effect of c.769C>T AIRE genotype?Ital J Pediatr. 2021 Jun 2;47(1):126. doi: 10.1186/s13052-021-01075-8. Ital J Pediatr. 2021. PMID: 34078422 Free PMC article.
-
Delay in the Diagnosis of APECED: A Case Report and Review of Literature from Iran.Immunol Invest. 2020 Apr;49(3):299-306. doi: 10.1080/08820139.2019.1671451. Epub 2019 Oct 7. Immunol Invest. 2020. PMID: 31588815 Review.
-
Autoimmune polyendocrine syndrome type 1 (APECED) in the Indian population: case report and review of a series of 45 patients.J Endocrinol Invest. 2021 Apr;44(4):661-677. doi: 10.1007/s40618-020-01376-5. Epub 2020 Aug 7. J Endocrinol Invest. 2021. PMID: 32767280 Review.
Cited by
-
Where AIRE we now? Where AIRE we going?Curr Opin Allergy Clin Immunol. 2024 Dec 1;24(6):448-456. doi: 10.1097/ACI.0000000000001041. Epub 2024 Oct 23. Curr Opin Allergy Clin Immunol. 2024. PMID: 39440452 Free PMC article. Review.
-
Immune cell subsets in autoimmune polyendocrine syndrome type I.Sci Rep. 2025 Aug 4;15(1):28398. doi: 10.1038/s41598-025-12634-y. Sci Rep. 2025. PMID: 40759705 Free PMC article.
-
Autoimmune hyperglycemia: beyond type 1 diabetes.Acta Diabetol. 2025 Apr 19. doi: 10.1007/s00592-025-02506-2. Online ahead of print. Acta Diabetol. 2025. PMID: 40252101
-
Delayed diagnosis of the full triad autoimmune polyendocrine syndrome type 2 with adrenal crisis: a case report and literature review.Front Immunol. 2025 May 9;16:1563629. doi: 10.3389/fimmu.2025.1563629. eCollection 2025. Front Immunol. 2025. PMID: 40416965 Free PMC article. Review.
References
-
- Whitaker J, Landing BH, Esselborn VM, Williams RR. The syndrome of familial juvenile hypoadrenocorticism, hypoparathyroidism and superficial moniliasis. J Clin Endocrinol Metab. 1956;16(10):1374‐1387. - PubMed
-
- Proust-Lemoine E, Saugier-Veber P, Wémeau JL. Polyglandular autoimmune syndrome type I. Presse Médicale. 2012;41(12):e651‐e662. - PubMed
-
- Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome. Ann N Y Acad Sci. 2011;1246(1):77‐91. - PubMed
-
- Aaltonen J, Björses P, Sandkuijl L, Perheentupa J, Peltonen L. An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat Genet. 1994;8(1):83‐87. - PubMed
-
- Morimoto J, Matsumoto M, Miyazawa R, Yoshida H, Tsuneyama K, Matsumoto M. Aire suppresses CTLA-4 expression from the thymic stroma to control autoimmunity. Cell Rep. 2022;38(7):110384. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials